06/17/2021
Two new monoclonal antibodies have been added to the rapidly expanding infusion therapy arsenal: ADUHELM (aducanumab-avwa), the first of it's kind Alzheimer's infusion treatment, and, another new COVID-19 EUA, Sotrovimab.
RxWORKFLOW for IV Safety™ drug monographs and Drug Specific Competency Tracking Courses are now available for both of these exciting new drugs.
Please let us know if you would like to add either of these new treatment options to your RxTOOLKIT Library and/or RxTOOLKIT eLEARNING or contact us today to get started with RxTOOLKIT ([email protected]).